C3 glomerulopathy - understanding a rare complement-driven renal disease.

Area of Science:

• Nephrology
• Immunology
• Rare Diseases

Background:

• C3 glomerulopathies are rare kidney diseases characterized by complement dysregulation.
• Prominent C3 deposition in kidney biopsies is a hallmark.
• Dense deposit disease (DDD) and C3 glomerulonephritis (C3GN) are major subgroups with overlapping features.

Purpose of the Study:

• To review the pathogenesis, clinical features, and treatment landscape of C3 glomerulopathies.
• To highlight the role of complement alternative pathway dysregulation.
• To discuss current therapeutic options and future directions.

Main Methods:

• Review of existing literature on C3 glomerulopathies.
• Analysis of pathogenic mechanisms involving complement system.
• Summary of clinical and pathological findings.

Main Results:

• Complement alternative pathway dysregulation is central to C3 glomerulopathies.
• Acquired factors, like autoantibodies targeting convertases, are common drivers.
• Genetic factors play a less frequent role.
• No universally effective or curative treatments are currently available.

Conclusions:

• C3 glomerulopathies represent a spectrum of complement-mediated kidney diseases.
• Targeting the alternative complement pathway is a focus for new therapies.
• High recurrence rates post-renal transplantation necessitate further research.